Answer
Verdict
Not enough evidence
Estrogen plus progestin adds about one breast cancer case per 1,000 women each year.
No counted mention yet.
By Arun AgrahriLast reviewed
Short answer
The risk is small, far smaller than the original fear suggested. The WHI found about one extra breast-cancer case per 1,000 women each year with estrogen plus progestin, and estrogen alone showed no increase. The original fear overstated this absolute risk, and the FDA removed the boxed warning in November 2025. Personal or family history still needs specialist care.
Hormone therapy around menopause does more good than harm for most women.
The verdict on HRT & Menopause overall. 12 sources: 4 positive, 8 partly
positive partly neutral negative Each researcher and each study counts once per claim, however often they come up.
Estrogen plus progestin adds about one breast cancer case per 1,000 women each year.
No counted mention yet.
Researchers say
No researcher counted yet.
Studies show
No study counted yet.
Precis is not affiliated with or endorsed by YouTube or by any researcher, show or publisher we quote. We take no sponsorship, ad or affiliate money, and every verdict is our own review of what was said. How we stay independent
Estrogen plus progestin adds about one breast cancer case per thousand women each year, and estrogen alone adds none.
The signal behind the post-2002 panic came from one arm of the Women's Health Initiative (WHI): estrogen plus a synthetic progestin. Researchers put it at a 24-26% relative increase. A relative jump on a rare event is still a small absolute number, about one extra case per 1,000 women per year.
The WHI's estrogen-alone arm showed no rise in breast cancer at all.
Sharon Malone, an OB/GYN and guest on Mark Hyman's show, walks through the data. The absolute breast-cancer signal came to less than one extra case per thousand women on estrogen. Avrum Bluming and Carol Tavris, authors of "Estrogen Matters," and JoAnn Manson, who led the WHI, made the case as guests on Peter Attia's show.
Their argument is that heart disease kills more women than breast cancer, and estrogen may help there. Mary Claire Haver, a guest on Andrew Huberman's show, carries the same reframe, while Huberman himself flags concerns about estrogen-dependent conditions.
In November 2025 the FDA removed the boxed warning for breast cancer, along with the ones for cardiovascular disease and dementia. It kept the endometrial-cancer warning for systemic estrogen-only therapy in women with a uterus. Of the three warnings, breast cancer is the one the modern reading pushes back on hardest.
A small absolute risk across a population is not zero risk for you. A personal or strong family history of hormone-sensitive cancer calls for an individual decision made with a specialist. A history of cancer does not settle the question in either direction, so take it to a menopause-trained physician.
Precis membership
The answer above is the whole answer: the verdict, every counted mention, where the sources disagree, and the receipt behind each one. Nothing on this page is held back.
A free account adds
Pro adds
Full HRT & Menopause evidence report
The verdict on every claim, and where the sources disagree